Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Montelukast Sodium (generic montelukast) submitted by Ajanta Pharma USA Inc. under ANDA203328.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma [Phase 3]
A Phase 3 study evaluating tezepelumab in adults with severe uncontrolled asthma has completed, and its results were posted on 2025-07-01.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps [NA]
This clinical trial update evaluates tezepelumab’s effect on barrier function in severe asthma patients, with and without chronic rhinosinus…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting
An observational real-world study evaluating treatment pathways for asthma patients treated with triple therapy (ICS/LABA/LAMA); the study i…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps [Phase 4]
Phase 4 real-world head-to-head trial in Danish patients compares dupilumab with mepolizumab for chronic rhinosinusitis with nasal polyps an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2025-06-30EMA Withdrawn: BroPair Spiromax (salmeterol xinafoate;fluticasone propionate) — Teva B.V.
EMA has withdrawn BroPair Spiromax, a salmeterol xinafoate and fluticasone propionate inhaler for asthma. The withdrawal decision was made o…
-
FDA approval · 2025-06-30FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)
FDA approved a supplemental application for epinephrine from BPI Labs, LLC, confirming regulatory action on the product.
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity [NA]
A clinical trials update on digitally implementing the German S3 guideline for multimorbidity across several conditions, currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Effect of Fasting and Refeeding on T-cell Fate
An NHLBI-sponsored clinical trial examined how fasting and refeeding affect T-cell fate, in conditions including asthma and inflammation, an…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Near Fatal Asthma in Children and Young People
An update on a University of Edinburgh clinical trial investigating near fatal asthma in children and young people, currently in recruitment…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Experience of Biologic Treatments for Severe Asthma: a Survey
A clinical trial survey examining experiences with biologic therapies for severe asthma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Pharmacist Counseling & Self-Management Program for Asthma Patients in a Midwest Chain Pharmacy, USA [NA]
This clinical trial update describes a pharmacist-led counseling and self-management program for asthma patients in a Midwest chain pharmacy…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB) [NA]
A clinical trial update indicates the Inspiratory Muscle Training for Exercise-Induced Bronchoconstriction (IMT_EIB) study has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Bronchial Thermoplasty: Effect on Neuronal and Chemosensitive Component of the Bronchial Mucosa [NA]
The trial studied the effect of bronchial thermoplasty on neuronal and chemosensitive components of the bronchial mucosa in severe persisten…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Effectiveness of 1st Rib Mobilization and Scalene Muscles Muscle Energy Technique Among Patients With Asthma [EARLY_Phase 1]
An early-phase Phase 1 trial update evaluating the effectiveness of first rib mobilization and scalene muscle muscle energy technique as a t…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland [NA]
A clinical trial update from the University of Geneva evaluating the myCare Start Service in Switzerland to support patients starting new me…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Asthma Inflammation Research [EARLY_Phase 1]
Early Phase 1 clinical trial update for asthma inflammation research; enrollment is ongoing by invitation at The Cleveland Clinic.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma [NA]
This clinical trial update covers the prevalence of obstructive sleep apnea and the diagnostic accuracy of a Type 3 home sleep test in peopl…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Treating Exacerbations of Asthma With Oral Montelukast in Children [Phase 2]
Phase 2 clinical trial evaluating oral montelukast to treat asthma exacerbations in pediatric patients, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Methacholine Challenge Test in School Children With/Without Asthma RISKA
This clinical trial is evaluating the methacholine challenge test in school-aged children with and without asthma to assess bronchial hyperr…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Registry of Asthma Characterization and Recruitment 3 (RACR3)
RACR3 is an ongoing registry to characterize asthma and support recruitment, sponsored by the National Institute of Allergy and Infectious D…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern [Phase 2, Phase 3]
A clinical trial update for a Phase 2/3 study evaluating the DASH dietary pattern to improve quality of life and clinical outcomes in uncont…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple Indications
A retrospective analysis sponsored by GlaxoSmithKline evaluating long-term systemic glucocorticoid effects, patient pathways, and the econom…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Effects of Buteyko Breathing Exercise in Children With Uncontrolled Asthma [NA]
A clinical trial update notes a study evaluating the effects of the Buteyko breathing exercise in children with uncontrolled asthma; the tri…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Effects of the Kata® Inhalations-App on Inhaler Handling Errors, Adherence, and Asthma Control in Patients With Asthma. [NA]
A completed clinical trial assessed the Kata Inhalations-App's impact on inhaler handling errors, adherence, and asthma control in patients …